oligonucteotid
contain
multipl
bind
site
introduc
regulatori
sequenc
long
termin
repeat
ltr
felin
immunodefici
viru
fiv
chloramphenicol
acetyltransferas
assay
reveal
basal
promot
activ
mutat
ltr
higher
wildtyp
ltr
crandel
felin
kidney
crfk
cell
mutat
ltr
introduc
infecti
molecular
clone
fiv
clone
transfect
crfk
cell
viru
product
mutant
cell
high
wildtyp
determin
revers
transcriptas
activ
assay
growth
mutant
viru
obtain
transfect
crfk
cell
examin
felin
lymphoblastoid
cell
line
cell
primari
felin
peripher
blood
mononuclear
cell
fpbmc
growth
delay
compar
wildtyp
viru
cell
use
upon
examin
polymeras
chain
reaction
length
ltr
mutant
viru
shorten
cell
fpbmc
sequenc
analysi
reveal
insert
complet
delet
day
infect
cell
miyazawa
et
al
sever
put
bind
site
enhanc
protein
cebp
present
previous
report
delet
relat
sequenc
ltr
promot
activ
reduc
crandel
felin
kidney
crfk
andf
catu
whole
cell
use
chloramphenicol
acetyltransferas
cat
assay
recent
thompson
et
al
report
protein
present
nuclear
extract
felin
cell
cell
permiss
fiv
replic
bind
put
bind
site
find
suggest
felin
cell
bind
bind
site
l
r
critic
basal
promot
activ
ltr
convers
u
n
viru
lack
bind
site
replic
felin
lymphoblastoid
cell
line
cell
primari
felin
peripher
blood
mononuclear
cell
fpbmc
data
indic
bind
site
necessari
effici
replic
fiv
felin
lymphocyt
studi
introduc
oligonucleotid
contain
multipl
bind
site
adjac
origin
bind
site
region
l
r
examin
effect
insert
promot
growth
activ
mutant
cell
cultur
crfk
cell
maintain
dulbecco
modifi
eagl
medium
supplement
heatinactiv
foetal
calf
serum
fc
fpbmc
obtain
specif
pathogenfre
cat
isol
describ
previous
cell
fpbmc
maintain
rpmi
growth
medium
supplement
fc
antibiot
gm
g
gml
polybren
unitsml
recombin
human
humidifi
atmospher
co
air
dna
construct
felin
immunodefici
viru
fiv
etiolog
agent
acquir
immunodefici
syndromelik
diseas
cat
fiv
member
genu
lentiviru
famili
retrovirida
lentiviru
express
regul
viral
encod
protein
cellular
transcript
factor
like
lentivirus
fiv
contain
rev
gene
howev
clear
whether
viru
contain
transactiv
gene
also
region
fiv
ltr
cat
construct
control
ltr
fiv
term
p
sptm
psptm
pvcat
describ
previous
made
place
fiv
ltr
infecti
clone
offiv
strain
delet
mutant
front
cat
gene
ofpspcat
cat
gene
poli
signal
infecti
clone
fiv
term
mutat
infecti
clone
lack
base
pair
fragment
contain
one
one
bind
site
term
describ
previous
ltr
deriv
strain
fiv
respect
digest
sad
small
fragment
contain
ltr
subclon
saci
site
p
vector
promega
madison
wi
usa
design
introduc
oligonucleotid
contain
multipl
bind
site
oligonucleotid
synthes
oligonucleotid
anneal
phosphoryl
dna
kinas
ligat
nhei
site
design
sequenc
determin
cycl
sequenc
method
use
dyetermin
suppli
appli
biosystem
abi
foster
citi
ca
usa
gener
mutat
ltr
end
fiv
genom
saci
fragment
contain
ltr
substitut
saci
fragment
gener
mutat
ltr
side
genom
bamhi
fragment
introduc
bamhi
site
construct
sacinari
fragment
clone
pspcat
pvisltrcat
visna
viru
ltr
cat
report
plasmid
kindli
provid
dr
j
e
clement
john
hopkin
univeristi
md
usa
transfect
plasmid
dna
crfk
cell
cell
plate
sixwel
dish
one
day
transfect
plasmid
dna
transfect
calcium
phosphat
coprecipit
method
four
hour
transfect
cell
wash
phosphatebuff
salin
pb
shock
glycerol
place
fresh
medium
cat
assay
cell
monolay
well
sixweu
dish
harvest
scrape
h
transfect
wash
pb
cell
tyse
freez
thaw
four
time
ph
cell
debri
pellet
centrifug
min
variou
amount
extract
assay
cat
activ
solvent
partit
method
brief
gl
reaction
mixtu
contain
ph
mmchloramophenicol
kbq
acetylcoenzym
du
pont
nen
cell
extract
overlaid
ml
scintil
fluid
econofluorii
du
point
nen
reaction
carri
product
radioact
label
acetylchloramphenicol
monitor
count
liquid
scintil
counter
cat
activ
promot
plasmid
present
net
dpm
product
formedh
cat
assay
data
report
paper
point
linear
rang
assay
cell
fpbmc
x
cell
infect
fiv
deriv
infecti
molecular
clone
cell
seed
x
cellsml
growth
medium
cell
number
adjust
x
ml
tyesh
growth
medium
indic
time
rt
activ
cell
cultur
supernat
assay
describ
previous
amplif
offiv
ltr
antisens
primer
n
nucleotid
sens
primer
nucleotid
synthes
correspond
primer
bind
site
upstream
sequenc
polypurin
tract
fiv
respect
sequenc
primer
origin
fiom
sequenc
fiv
strain
pcr
carri
method
saiki
et
al
gl
volum
overlaid
equal
volum
miner
oil
geneamp
pcr
reagent
kit
perkin
elmer
cetu
norwalk
ct
usa
use
reaction
amplif
proceed
cycl
dna
thermal
cycler
model
p
perkin
elmer
cetu
norwalk
ct
usa
one
cycl
consist
incub
rain
respect
amplif
gl
sampl
glreaction
electrophores
agaros
gel
trisborateedta
buter
amplifi
dna
digest
xbai
nari
subclon
use
sequenc
analysi
doubl
strand
dna
anneal
primer
extend
cycl
sequenc
method
use
dyetermin
suppli
abi
analyz
model
abi
autosequenc
oligonucleotid
contain
two
site
synthes
insert
nhei
site
fiv
ltr
gener
sequenc
analysi
reveal
five
bind
site
fig
insert
plasmid
stabl
e
coli
mutat
ltr
contain
five
site
place
upstream
cat
gene
poli
signal
ofpspcat
construct
sequenc
region
pvcat
shown
fig
schemat
view
ltr
cat
report
plasmid
shown
fig
ltr
strain
differ
tm
strain
posit
g
c
ltr
show
almost
promot
activ
crfk
cell
unpubl
data
two
tg
pspcat
pvisltrcat
transfect
crfk
cell
fortyeight
hour
transfect
cat
product
clone
measur
solvent
partit
method
basal
promot
activ
significantli
higher
psptm
cat
crfk
cell
fig
addit
activ
lower
pvisltrcat
cell
type
fig
mutat
ltr
introduc
infecti
molecular
clone
fiv
term
design
five
gg
wildtyp
apldelet
mutant
transfect
crfk
cell
three
day
transfect
viru
product
cultur
supernat
measur
use
rt
activ
assay
shown
fig
rt
activ
similar
sampl
cultur
supernat
contain
equival
radioact
crfk
cell
transfect
respect
infecti
molecular
clone
inocul
cell
cell
fpbmc
viru
product
monitor
rt
activ
assay
shown
fig
growth
viru
deriv
delay
cell
howev
peak
rt
activ
virus
occur
similar
level
either
fig
fig
cell
hand
peak
rt
activ
viru
lower
fpbmc
fig
cultur
supernat
cell
infect
viru
day
infect
fig
transfer
onto
cell
fpbmc
viru
product
monitor
rt
activ
assay
fig
cell
fig
growth
viru
similar
viru
hand
fpbmc
fig
growth
rate
mutant
lower
viru
determin
stabil
insert
multipl
bind
site
infect
experi
fig
c
fig
fpbmc
harvest
final
sampl
time
amplifi
pcr
shown
fig
length
mutant
ltr
shorten
cell
fpbmc
harvest
differ
time
partial
nucleotid
sequenc
pcr
product
obtain
cell
harvest
day
infect
fig
day
infect
fig
compar
region
plasmid
sequenc
three
type
delet
sequenc
del
fig
obtain
cell
infect
fiv
deriv
crfk
cell
transfect
harvest
day
infect
fig
sequenc
ofdel
two
bind
site
ofdel
ltr
lentivirus
contain
mani
bind
site
cellular
transcript
factor
fiv
visna
viru
caprin
arthritisenceph
viru
caev
possess
put
bind
site
cebp
ltr
n
r
bind
site
shown
critic
effici
transcript
ofvisna
viru
fiv
although
fiv
one
bind
site
region
ltr
visna
viru
caev
multipl
bind
site
region
addit
found
promot
activ
ofvisna
viru
caev
ltr
rather
higher
fiv
ltr
crfk
human
colon
carcinoma
cell
suggest
high
promot
activ
visna
viru
caev
partli
due
multuipl
copi
bind
site
ltr
studi
insert
multipl
bind
site
adjac
origin
bind
site
enhanc
region
fiv
ltr
signific
enhanc
promot
activ
observ
crfk
cell
data
suggest
insert
effect
least
cell
howev
activ
mutant
ltr
still
lower
visna
viru
ltr
might
possibl
high
promot
activ
visna
viru
attribut
multipl
copi
bind
site
contrast
crfk
cell
cell
signific
enhanc
promot
activ
observ
insert
delet
site
togeth
one
site
two
promot
activ
significantli
reduc
cell
reason
discrep
unknown
present
howev
possibl
promot
activ
cell
less
depend
site
delet
site
examin
whether
insert
posit
effect
replic
capabl
fiv
construct
infecti
molecular
clone
contain
mutat
ltr
side
genom
firstli
mutant
infecti
clone
transfect
crfk
cell
transient
viru
product
mutant
miyazawa
et
al
compar
wildtyp
delet
mutant
expect
viru
product
would
correl
result
cat
assay
howev
signific
differ
observ
among
infecti
clone
previous
demonstr
presenc
suppressor
genelik
activ
fiv
similar
nefgen
activ
primat
lentivirus
reduc
promot
activ
ltr
possibl
suppressor
genelik
activ
abrog
enhanc
reduct
promot
activ
caus
insert
delet
respect
next
viru
product
mutant
infecti
clone
compar
wildtyp
felin
lymphocyt
growth
mutant
viru
delay
cell
cell
fpbmc
addit
mutat
viru
harvest
cell
day
infect
fig
transfer
onto
normal
fpbmc
growth
mutant
viru
chang
level
wildtyp
fiv
cell
fig
pcr
analysi
amplifi
ltr
cultur
reveal
length
ltr
shorten
similar
wildtyp
viru
sequenc
analysi
reveal
insert
multipl
bind
site
complet
delet
data
indic
multipl
bind
site
introduc
ltr
neg
effect
viral
growth
activ
felin
lymphocyt
delet
occur
day
previous
also
report
mutant
grew
well
wildtyp
cell
primari
fpbmc
conclud
site
requir
replic
fiv
felin
lymphocyt
mechan
delay
viral
growth
insert
mutant
felin
lymphocyt
unclear
present
howev
sinc
bind
site
tga
gc
tca
contain
palindrom
sequenc
possibl
multipl
bind
site
introduc
ltr
readili
form
secondari
structur
mrna
level
inhibit
revers
transcript
full
length
genom
rna
complementari
dna
felin
lymphocyt
visna
viru
caev
multipl
bind
site
howev
site
virus
slightli
differ
consensu
sequenc
present
dispersedli
therefor
unlik
mrna
region
virus
form
strong
secondari
structur
nevertheless
present
studi
togeth
previou
studi
demonstr
linear
relationship
promot
activ
viru
determin
cat
assay
viral
replic
capabl
therefor
understand
signific
enhanc
promot
bind
site
regard
viru
life
cycl
necessari
construct
infecti
clone
lack
bind
site
compar
growth
rate
mutant
virus
